Healthcare IT News January 16, 2025
Andrea Fox

The rule would establish a framework for a telehealth controlled substance registry and authorize three types of special registration. Some industry groups have voiced concerns for providers in their initial reactions to the proposed rule.

The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the Ryan Haight Online Pharmacy Consumer Protection Act.

WHY IT MATTERS

The NPRM comes two months after the DEA and U.S. Health and Human Services announced they extended the pandemic-era virtual prescribing of controlled substances a third time. The most recent extension of COVID-19 flexibilities for prescribing runs through 2025.

“DEA has determined that the best course...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Mental Health, Patient / Consumer, Provider, Technology, Telehealth
Are third-party telehealth prescriptions of GLP-1s safe?
Unifying telemedicine efforts can help health systems succeed with virtual care
Telehealth For Menopause: Shifting Care Norms And Expanding Access
Communicating with your doctor online could cost you
Iris Telehealth Acquires innovaTel to Expand Telepsychiatry Services

Share This Article